BF
ANIP icon

BOK Financial’s ANI Pharmaceuticals ANIP Stock Holding History

BOK Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Buy
+6,015
New +$483K 0.01% 559
2023
Q4 		– Sell
-19
Closed -$1.17K – 1260
2023
Q3 		$1.17K Buy
+19
New +$1.1K ﹤0.01% 1076

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BOK Financial's ANIP Position: Q2 2026 in Review

BOK Financial opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 6,015 shares worth $498K. The stake represents 0.01% of the portfolio and ranks #559 among its holdings. This is a return to the name: BOK Financial previously reported a position in ANIP as recently as Q3 2023.

BOK Financial first reported a position in ANIP in Q3 2023 and has held it in 2 quarters since. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • BOK Financial held 6,015 shares of ANI Pharmaceuticals worth $498K as of Q2 2026.
  • ANI Pharmaceuticals was a new BOK Financial position in Q2 2026.
  • ANI Pharmaceuticals made up 0.01% of BOK Financial's portfolio in Q2 2026, its #559 holding.
  • BOK Financial first reported a position in ANI Pharmaceuticals in Q3 2023 and has held it in 2 quarters since.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.